爱朋医疗
(300753)
| 流通市值：19.20亿 | | | 总市值：27.53亿 |
| 流通股本：8789.40万 | | | 总股本：1.26亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 68,309,666.37 | 342,017,501.52 | 251,646,851.61 | 159,166,688.58 |
| 营业收入 | 68,309,666.37 | 342,017,501.52 | 251,646,851.61 | 159,166,688.58 |
| 二、营业总成本 | 74,421,112.85 | 383,256,597.4 | 281,294,518.85 | 183,044,550.6 |
| 营业成本 | 23,104,344.61 | 107,944,429.14 | 88,329,271.54 | 58,538,084.09 |
| 税金及附加 | 812,669.7 | 4,086,538.44 | 3,068,727.85 | 2,029,365.16 |
| 销售费用 | 25,875,396.56 | 153,050,417.44 | 111,289,307.25 | 69,241,795.79 |
| 管理费用 | 14,185,424.36 | 74,796,465.71 | 47,914,651.21 | 33,507,563.5 |
| 研发费用 | 9,811,466.29 | 40,557,741.83 | 28,911,852.32 | 18,753,949.82 |
| 财务费用 | 631,811.33 | 2,821,004.84 | 1,780,708.68 | 973,792.24 |
| 其中:利息费用 | 695,193.85 | 3,258,134.21 | 2,400,926.74 | 1,570,417.24 |
| 其中:利息收入 | 90,257.14 | 497,514.97 | 662,763.91 | 628,478.48 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -445,318.84 | 1,545,267.93 | 1,430,769.71 | 1,010,455.62 |
| 资产处置收益 | - | 121,071.36 | 48,785.76 | 63,139.44 |
| 资产减值损失(新) | - | -1,607,262.04 | -857,973.28 | -274,673.04 |
| 信用减值损失(新) | -453,762.26 | 1,677,246.32 | -1,903,094.68 | -7,044,332.89 |
| 其他收益 | 506,084.29 | 12,532,425.4 | 10,211,462.98 | 4,325,562.46 |
| 四、营业利润 | -6,504,443.29 | -26,970,346.91 | -20,717,716.75 | -25,797,710.43 |
| 加:营业外收入 | 1.74 | 1,925,853.59 | 1,651,652.29 | 4,239.28 |
| 减:营业外支出 | 1,026,076.45 | 1,039,591.89 | 796,979.22 | 536,116.65 |
| 五、利润总额 | -7,530,518 | -26,084,085.21 | -19,863,043.68 | -26,329,587.8 |
| 减:所得税费用 | -2,299,833.7 | 747,369.68 | -7,574,631.34 | -6,476,275.36 |
| 六、净利润 | -5,230,684.3 | -26,831,454.89 | -12,288,412.34 | -19,853,312.44 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -5,230,684.3 | -26,831,454.89 | -12,288,412.34 | -19,853,312.44 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -4,390,879.26 | -24,020,678.42 | -11,484,204.86 | -19,379,092.01 |
| 少数股东损益 | -839,805.04 | -2,810,776.47 | -804,207.48 | -474,220.43 |
| 扣除非经常损益后的净利润 | -3,683,162.72 | -28,166,243.11 | -14,305,008.95 | -20,141,917.33 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.03 | -0.19 | -0.09 | -0.15 |
| (二)稀释每股收益 | -0.03 | -0.19 | -0.09 | -0.15 |
| 九、综合收益总额 | -5,230,684.3 | -26,831,454.89 | -12,288,412.34 | -19,853,312.44 |
| 归属于母公司股东的综合收益总额 | -4,390,879.26 | -24,020,678.42 | -11,484,204.86 | -19,379,092.01 |
| 归属于少数股东的综合收益总额 | -839,805.04 | -2,810,776.47 | -804,207.48 | -474,220.43 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-28 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |